News AptarGroup, Inc.

Stocks

ATR

US0383361039

Non-Paper Containers & Packaging

Market Closed - NYSE 02:30:02 03/11/2026 am IST			5-day change	1st Jan Change
143.86 ^USD	+4.85%		+13.68%	+17.96%

30/10	AptarGroup, Inc., Q3 2026 Earnings Call, Oct 30, 2026
30/10	AptarGroup Q3 Adjusted Earnings Fall, Sales Rise; Dividend Increased	MT

All News

Mentions Relevance

30/10	AptarGroup, Inc., Q3 2026 Earnings Call, Oct 30, 2026
30/10	AptarGroup : Third Quarter 2026 Historical Financials	PU
30/10	AptarGroup Q3 Adjusted Earnings Fall, Sales Rise; Dividend Increased	MT
30/10	AptarGroup Q3 Adjusted Earnings Fall, Sales Rise	MT
30/10	(ATR) AptarGroup, Inc. Expects Q4 Adjusted EPS Range $1.39 - $1.47	MT
30/10	Earnings Flash (ATR) AptarGroup, Inc. Reports Q3 Revenue $1.02B, vs. FactSet Est of $980.8M	MT
30/10	Earnings Flash (ATR) AptarGroup, Inc. Posts Q3 Adjusted EPS $1.52 per Share, vs. FactSet Est of $1.47	MT
30/10	Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on February 5, 2026.	CI
30/10	Aptar Reports Third Quarter 2026 Results	BU
30/10	AptarGroup, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
30/10	Aptar Increases Quarterly Dividend to $0.50 Per Share	BU
30/10	Aptargroup, Inc Declares Quarterly Cash Dividend, Payable on December 3, 2026	CI
23/10	Aptar Taps Pharma Packaging Veteran Virginie Maes as President of its Pharma Business	BU
23/10	AptarGroup, Inc. Announces Appointment of Virginie Maes as President of Aptar Pharma, Effective January 1, 2027	CI
09/10	UBS Initiates Coverage on AptarGroup With Neutral Rating, $135 Price Target	MT
22/09	AptarGroup Russian Subsidiary Placed Under Temporary State Control	MT
21/09	Russia puts Aptar Europe Holding under temporary administration	RE
15/09	AptarGroup, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 11:30 AM
15/09	AptarGroup, Mass General Partner on Nose-to-Brain Drug Delivery Research	MT
15/09	Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery	BU
15/09	Aptargroup, Inc. and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-To-Brain Drug Delivery	CI
11/09	Aptargroup, Inc. Announces Management Changes, Effective from September 11, 2026	CI
09/09	AptarGroup, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 12:45 PM
01/09	AptarGroup, Inc. Announces Appointment of Gael Touya as Director, Effective September 1, 2026	CI
04/08	Aptargroup Insider Sold Shares Worth $1,339,588, According to a Recent SEC Filing	MT